US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Septerna, Inc.

26.90

-0.1800-0.66%

Volume:58.85K

Turnover:1.55M

Market Cap:1.20B

PE:-18.87

High:27.27

Open:26.85

Low:25.49

Close:27.08

52wk High:31.37

52wk Low:4.66

Shares:44.77M

Float Shares:18.20M

Volume Ratio:0.43

T/O Rate:0.32%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.4257

EPS(LYR):-7.2588

ROE:-22.38%

ROA:-14.32%

PB:3.10

PE(LYR):-3.71

Loading ...

Overview Company News Filings

Septerna Grants Stock Options to New Chief Legal Officer Under 2026 Inducement Plan

Septerna Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Septerna to Present Phase 1 Trial Data for SEP-631 in Mast Cell Diseases at 2026 AAAAI Meeting

Septerna Is Maintained at Buy by HC Wainwright & Co.

Septerna Inc. Files Initial Beneficial Ownership Statement for Chief Legal Officer Mark Andrew Wilson

Septerna to Present GPCR Pipeline Updates at JPM Conference

Septerna Appoints Mark Wilson as Chief Legal Officer

Septerna appoints Mark Wilson as chief legal officer

Press Release: Septerna Expands Leadership with Appointment of Industry Veteran Mark A. Wilson as Chief Legal Officer

Septerna Initiated at Buy by Jones Trading

Septerna Inc : Jonestrading Initiates Coverage With Buy Rating; Target Price $43

THOMSON REUTERS

Raymond James Initiates Coverage on Septerna With Strong Buy Rating, $38 Price Target

MT Newswires Live

Septerna to Present at 44th Annual J.P. Morgan Healthcare Conference

Septerna Initiated at Buy by Truist Securities

Septerna Inc : Truist Securities Initiates Coverage With Buy Rating; Price Target $34

THOMSON REUTERS

Truist Initiates Septerna at Buy With $34 Price Target

MT Newswires Live

Septerna (SEPN) Is Up 9.9% After Swinging to Q3 Profit and Revenue Surge – Has the Bull Case Changed?

Simply Wall St.

Cantor Fitzgerald Sticks to Their Buy Rating for Septerna, Inc. (SEPN)

Septerna price target raised to $34 from $28 at JPMorgan

Septerna Inc : JP Morgan Raises Target Price to $34 From $28

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SEPN/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SEPN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SEPN\",,,,,undefined,":{"symbol":"SEPN","market":"US","secType":"STK","nameCN":"Septerna, Inc.","latestPrice":26.9,"timestamp":1771606773179,"preClose":27.08,"halted":0,"volume":58847,"delay":0,"changeRate":-0.006646971935007375,"floatShares":18202732,"shares":44774192,"eps":-1.425664,"marketStatus":"Trading","change":-0.18,"latestTime":"02-20 11:59:50 EST","open":26.85,"high":27.27,"low":25.49,"amount":1546532.70279,"amplitude":0.065731,"askPrice":26.94,"askSize":276,"bidPrice":26.32,"bidSize":9,"shortable":3,"etf":0,"ttmEps":-1.425664,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1771621200000},"marketStatusCode":2,"adr":0,"listingDate":1729828800000,"exchange":"NASDAQ","adjPreClose":27.08,"postHourTrading":{"tag":"盘后","latestPrice":27,"preClose":27.08,"latestTime":"17:37 EST","volume":9649,"amount":261244.45,"timestamp":1771540671932,"change":-0.08,"changeRate":-0.002954,"amplitude":0.006647},"volumeRatio":0.434456,"impliedVol":0.6825,"impliedVolPercentile":0.3984},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SEPN\",,,,,undefined,":{"symbol":"SEPN","floatShares":18202732,"roa":"-14.32%","roe":"-22.38%","lyrEps":-7.258829,"volumeRatio":0.434456,"shares":44774192,"dividePrice":0,"high":27.27,"amplitude":0.065731,"preClose":27.08,"low":25.49,"week52Low":4.66,"pbRate":"3.10","psRate":"54.63","week52High":31.37,"institutionHeld":0,"latestPrice":26.9,"committee":-0.936842,"eps":-1.425664,"divideRate":0,"volume":58847,"delay":0,"ttmEps":-1.425664,"open":26.85,"prevYearClose":27.88,"prevWeekClose":27.5,"prevMonthClose":23.34,"prevQuarterClose":27.88,"fiveDayClose":25.76,"twentyDayClose":26.67,"sixtyDayClose":25.56},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SEPN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-10","symbol":"SEPN","fiscalQuarterEnding":"2025/09","expectedEps":0.19,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"pre","actualEps":-0.09},{"market":"US","date":"2025-08-11","symbol":"SEPN","fiscalQuarterEnding":"2025/06","expectedEps":-0.05,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"post","actualEps":-0.56},{"market":"US","date":"2025-05-15","symbol":"SEPN","fiscalQuarterEnding":"2025/03","expectedEps":-0.38,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"post","actualEps":-0.49},{"market":"US","date":"2025-03-27","symbol":"SEPN","fiscalQuarterEnding":"2024/12","expectedEps":-0.69,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"pre","actualEps":-0.64}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SEPN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SEPN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.125,"buy":0.875,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.875,"analysts":8,"updateTime":1766552400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SEPN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SEPN","date":"2026-02-18","current":-18.994658,"percent":0.177914,"low":-71.269737,"twenty":-21.773067,"median":-11.239907,"eighty":-5.659331,"high":261.261398,"avg":-5.821838,"sd":59.913549,"marketCap":1356658017},"quantilePoints":[{"date":"2024-10-25","current":180.873276,"twenty":180.873276,"median":180.873276,"eighty":180.873276,"marketCap":756050292},{"date":"2024-10-31","current":204.688257,"twenty":197.111676,"median":204.688257,"eighty":209.813,"marketCap":855596913},{"date":"2024-11-08","current":261.261398,"twenty":203.984861,"median":216.997688,"eighty":242.57116,"marketCap":1092072644},{"date":"2024-11-15","current":224.885772,"twenty":207.743006,"median":230.613426,"eighty":256.156752,"marketCap":940022529},{"date":"2024-11-22","current":-56.371082,"twenty":203.984861,"median":228.503238,"eighty":245.706296,"marketCap":915240881},{"date":"2024-11-29","current":-69.163916,"twenty":-57.105794,"median":221.92146,"eighty":240.581553,"marketCap":1122945345},{"date":"2024-12-06","current":-68.890433,"twenty":-66.926823,"median":208.506693,"eighty":237.707678,"marketCap":1118505070},{"date":"2024-12-13","current":-61.725172,"twenty":-67.501138,"median":191.022276,"eighty":236.763117,"marketCap":1002169886},{"date":"2024-12-20","current":-63.995083,"twenty":-66.784612,"median":-58.207863,"eighty":234.592638,"marketCap":1039024162},{"date":"2024-12-27","current":-70.449288,"twenty":-68.420042,"median":-60.166317,"eighty":232.180994,"marketCap":1143814633},{"date":"2025-01-03","current":-58.388676,"twenty":-68.655237,"median":-61.232902,"eighty":229.769351,"marketCap":947998541},{"date":"2025-01-10","current":-57.02126,"twenty":-67.714455,"median":-60.412452,"eighty":226.39305,"marketCap":925797170},{"date":"2025-01-17","current":-46.437457,"twenty":-67.358927,"median":-58.853597,"eighty":224.885772,"marketCap":753958559},{"date":"2025-01-24","current":-50.266223,"twenty":-66.593173,"median":-57.614562,"eighty":220.142874,"marketCap":816122397},{"date":"2025-01-31","current":-48.433885,"twenty":-66.401735,"median":-55.982023,"eighty":215.822012,"marketCap":786372560},{"date":"2025-02-07","current":-38.861971,"twenty":-65.110894,"median":-50.840537,"eighty":209.813,"marketCap":630962963},{"date":"2025-02-14","current":-31.587316,"twenty":-64.153703,"median":-49.199638,"eighty":205.451944,"marketCap":512851670},{"date":"2025-02-21","current":-16.108164,"twenty":-63.748948,"median":-46.492154,"eighty":202.578068,"marketCap":261532150},{"date":"2025-02-28","current":-15.862029,"twenty":-63.55204,"median":-46.410109,"eighty":188.992476,"marketCap":257535903},{"date":"2025-03-07","current":-17.393535,"twenty":-63.169163,"median":-46.191322,"eighty":63.291545,"marketCap":282401439},{"date":"2025-03-14","current":-17.47558,"twenty":-62.928498,"median":-43.237703,"eighty":-15.145503,"marketCap":283733521},{"date":"2025-03-21","current":-16.81922,"twenty":-62.747999,"median":-39.764466,"eighty":-15.424456,"marketCap":273076863},{"date":"2025-03-28","current":-3.893469,"twenty":-62.08617,"median":-37.439858,"eighty":-15.424456,"marketCap":279543299},{"date":"2025-04-04","current":-3.590162,"twenty":-61.462628,"median":-35.44343,"eighty":-3.701581,"marketCap":257766476},{"date":"2025-04-11","current":-3.194007,"twenty":-61.271189,"median":-31.04035,"eighty":-3.397655,"marketCap":229323279},{"date":"2025-04-17","current":-3.707771,"twenty":-61.249311,"median":-18.610536,"eighty":-3.429843,"marketCap":266210551},{"date":"2025-04-25","current":-3.998698,"twenty":-60.904722,"median":-17.913153,"eighty":-3.49979,"marketCap":287098524},{"date":"2025-05-02","current":-4.419614,"twenty":-60.313998,"median":-17.530277,"eighty":-3.557975,"marketCap":317319421},{"date":"2025-05-09","current":-4.302005,"twenty":-59.827198,"median":-17.393535,"eighty":-3.586448,"marketCap":308875347},{"date":"2025-05-16","current":-5.700187,"twenty":-58.946582,"median":-17.1474,"eighty":-3.607494,"marketCap":450930380},{"date":"2025-05-23","current":-5.339701,"twenty":-58.316351,"median":-16.81922,"eighty":-3.64092,"marketCap":422413044},{"date":"2025-05-30","current":-5.553739,"twenty":-57.970542,"median":-16.682479,"eighty":-3.660728,"marketCap":439345212},{"date":"2025-06-06","current":-5.925491,"twenty":-56.891224,"median":-16.203883,"eighty":-3.697867,"marketCap":468753715},{"date":"2025-06-13","current":-5.863532,"twenty":-56.29327,"median":-16.053467,"eighty":-3.717675,"marketCap":463852298},{"date":"2025-06-20","current":-5.908593,"twenty":-55.982023,"median":-15.862029,"eighty":-3.757291,"marketCap":467416965},{"date":"2025-06-27","current":-6.122632,"twenty":-53.001056,"median":-15.383433,"eighty":-3.77586,"marketCap":484349134},{"date":"2025-07-03","current":-6.404261,"twenty":-51.513306,"median":-10.750269,"eighty":-3.795668,"marketCap":506628303},{"date":"2025-07-11","current":-6.578872,"twenty":-50.660039,"median":-6.404261,"eighty":-3.874899,"marketCap":520441387},{"date":"2025-07-18","current":-7.108336,"twenty":-50.32092,"median":-6.590137,"eighty":-3.893469,"marketCap":562326225},{"date":"2025-07-25","current":-7.6378,"twenty":-49.412955,"median":-6.753482,"eighty":-3.9727,"marketCap":604211063},{"date":"2025-08-01","current":-6.990051,"twenty":-48.587036,"median":-6.961888,"eighty":-3.99746,"marketCap":552968974},{"date":"2025-08-08","current":-6.590137,"twenty":-46.8805,"median":-6.764747,"eighty":-3.998698,"marketCap":521332554},{"date":"2025-08-15","current":-5.951139,"twenty":-46.492154,"median":-6.643647,"eighty":-4.11805,"marketCap":520754376},{"date":"2025-08-22","current":-5.961329,"twenty":-46.448396,"median":-6.601402,"eighty":-4.167728,"marketCap":521646079},{"date":"2025-08-29","current":-6.256848,"twenty":-46.3937,"median":-6.581688,"eighty":-4.266238,"marketCap":547505457},{"date":"2025-09-05","current":-7.194356,"twenty":-46.300716,"median":-6.581688,"eighty":-4.297053,"marketCap":629542106},{"date":"2025-09-12","current":-7.34721,"twenty":-46.213201,"median":-6.601402,"eighty":-4.305719,"marketCap":642917646},{"date":"2025-09-19","current":-8.121674,"twenty":-44.993466,"median":-6.643647,"eighty":-4.319893,"marketCap":710687051},{"date":"2025-09-26","current":-8.534381,"twenty":-43.94876,"median":-6.764747,"eighty":-4.33085,"marketCap":746801011},{"date":"2025-10-03","current":-10.266733,"twenty":-43.12831,"median":-6.961888,"eighty":-4.351524,"marketCap":898390470},{"date":"2025-10-10","current":-11.790184,"twenty":-42.592283,"median":-7.068908,"eighty":-4.39733,"marketCap":1031700023},{"date":"2025-10-17","current":-11.497212,"twenty":-40.869338,"median":-7.146788,"eighty":-4.427042,"marketCap":1006063571},{"date":"2025-10-24","current":-11.102338,"twenty":-39.518331,"median":-7.194356,"eighty":-4.55084,"marketCap":971510091},{"date":"2025-10-31","current":-10.949483,"twenty":-39.058879,"median":-7.339567,"eighty":-4.913908,"marketCap":958134551},{"date":"2025-11-07","current":-9.578887,"twenty":-37.155435,"median":-7.357401,"eighty":-5.147066,"marketCap":838200538},{"date":"2025-11-14","current":-14.648361,"twenty":-35.886473,"median":-7.487327,"eighty":-5.196633,"marketCap":861455454},{"date":"2025-11-21","current":-18.097273,"twenty":-35.585642,"median":-7.6378,"eighty":-5.267603,"marketCap":1064282543},{"date":"2025-11-28","current":-22.094357,"twenty":-33.900984,"median":-7.78988,"eighty":-5.319423,"marketCap":1299347051},{"date":"2025-12-05","current":-19.916898,"twenty":-31.401348,"median":-8.060532,"eighty":-5.378003,"marketCap":1171292862},{"date":"2025-12-12","current":-19.954966,"twenty":-31.056759,"median":-8.182815,"eighty":-5.451226,"marketCap":1173531572},{"date":"2025-12-19","current":-20.96756,"twenty":-27.412726,"median":-8.753473,"eighty":-5.501919,"marketCap":1233081247},{"date":"2025-12-26","current":-22.436964,"twenty":-22.503963,"median":-9.413294,"eighty":-5.544727,"marketCap":1319495438},{"date":"2026-01-02","current":-21.226419,"twenty":-22.436964,"median":-9.632386,"eighty":-5.553739,"marketCap":1248304472},{"date":"2026-01-09","current":-19.597131,"twenty":-22.436964,"median":-9.915167,"eighty":-5.569002,"marketCap":1152487702},{"date":"2026-01-16","current":-20.845744,"twenty":-22.436964,"median":-10.381374,"eighty":-5.593168,"marketCap":1225917376},{"date":"2026-01-23","current":-20.305186,"twenty":-22.162878,"median":-10.567347,"eighty":-5.611192,"marketCap":1194127700},{"date":"2026-01-30","current":-18.120114,"twenty":-22.094357,"median":-10.857771,"eighty":-5.615698,"marketCap":1065625769},{"date":"2026-02-06","current":-18.607377,"twenty":-21.850725,"median":-11.071767,"eighty":-5.615698,"marketCap":1094281252},{"date":"2026-02-13","current":-19.612358,"twenty":-21.722819,"median":-11.209336,"eighty":-5.64356,"marketCap":1153383185},{"date":"2026-02-18","current":-23.068884,"twenty":-21.773067,"median":-11.239907,"eighty":-5.659331,"marketCap":1356658017}],"updateTime":1771573023355},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SEPN\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2610167690","title":"Septerna Grants Stock Options to New Chief Legal Officer Under 2026 Inducement Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2610167690","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610167690?lang=en_us&edition=fundamental","pubTime":"2026-02-11 05:05","pubTimestamp":1770757508,"startTime":"0","endTime":"0","summary":"Septerna Inc. has announced that its Board of Directors granted a non-qualified stock option to Mark A. Wilson, the company’s Chief Legal Officer. The award allows Wilson to purchase 165,000 shares of common stock at an exercise price of $25.41 per share, matching the closing share price on February 6, 2026. The options will vest over four years: 25% after one year and the remaining 75% in equal monthly installments over the following 36 months, contingent on Wilson’s continued employment.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Septerna Inc. published the original content used to generate this news brief via GlobeNewswire  on February 10, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nNDL2LcCC4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","IE00BKPKM429.USD","BK4007","BK4588","BK4585","IE00B64PRP62.GBP","LU2210149790.SGD","LU0314104364.USD","LU2210150020.SGD","SG9999014013.SGD","SG9999014039.USD","IE00B3QW5Z07.USD","LU2095319765.USD","BK4112","SG9999014021.USD","SG9999014005.SGD","SEPN","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2610679435","title":"Septerna Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2610679435","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610679435?lang=en_us&edition=fundamental","pubTime":"2026-02-11 05:05","pubTimestamp":1770757500,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., Feb.  10, 2026  (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug di","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/10/3235766/0/en/Septerna-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","BK4007","SEPN","GPCR"],"gpt_icon":0},{"id":"2610288346","title":"Septerna to Present Phase 1 Trial Data for SEP-631 in Mast Cell Diseases at 2026 AAAAI Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2610288346","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610288346?lang=en_us&edition=fundamental","pubTime":"2026-02-10 21:00","pubTimestamp":1770728418,"startTime":"0","endTime":"0","summary":"Septerna Inc., a clinical-stage biotechnology company, has announced plans to present data from its Phase 1 clinical trial of SEP-631 at the 2026 American Academy of Allergy Asthma & Immunology  Annual Meeting, scheduled for February 27-March 2, 2026, in Philadelphia. SEP-631 is a selective oral small molecule Mas-related G protein-coupled receptor X2  negative allosteric modulator, being developed for the treatment of chronic spontaneous urticaria and other mast cell-driven diseases. The results from the first-in-human, proof-of-mechanism study will be shared during a late breaking poster session on March 1, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Septerna Inc. published the original content used to generate this news bri","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nNDL2t0N2s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1721427968.SGD","LU2413665964.HKD","SG9999014013.SGD","LU2413666004.HKD","LU2095319765.USD","BK4086","LU0170899867.USD","SG9999001440.SGD","BK4007","SG9999014005.SGD","BK4112","IE00BKPKM429.USD","BK4585","LU2210150020.SGD","LU1543694498.USD","SG9999014021.USD","SEPN","LU0314104364.USD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","LU1620156130.USD","SG9999014039.USD","BK4588","LU2210149790.SGD","LU1165135440.EUR","IE00B3QW5Z07.USD","NDAQ","LU1620156213.USD","MAS","LU1596574779.USD"],"gpt_icon":0},{"id":"2604190370","title":"Septerna Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2604190370","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604190370?lang=en_us&edition=fundamental","pubTime":"2026-01-20 20:03","pubTimestamp":1768910580,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SEPN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 20, 2026 07:03 ET (12:03 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SEPN"],"gpt_icon":0},{"id":"2603497935","title":"Septerna Inc. Files Initial Beneficial Ownership Statement for Chief Legal Officer Mark Andrew Wilson","url":"https://stock-news.laohu8.com/highlight/detail?id=2603497935","media":"Reuters","labels":["executive","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603497935?lang=en_us&edition=fundamental","pubTime":"2026-01-16 05:17","pubTimestamp":1768511853,"startTime":"0","endTime":"0","summary":"Septerna Inc. has filed an initial statement of beneficial ownership  with the U.S. Securities and Exchange Commission. The filing names Mark Andrew Wilson as the beneficial owner, serving in the role of Chief Legal Officer at Septerna Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Septerna Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 15, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nNDL4sRQ4n:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Septerna Inc. Files Initial Beneficial Ownership Statement for Chief Legal Officer Mark Andrew Wilson","news_tag":"executive,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SEPN"],"gpt_icon":0},{"id":"2602130545","title":"Septerna to Present GPCR Pipeline Updates at JPM Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2602130545","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602130545?lang=en_us&edition=fundamental","pubTime":"2026-01-12 22:13","pubTimestamp":1768227190,"startTime":"0","endTime":"0","summary":"An update from Septerna, Inc. ( ($SEPN) ) is now available. Septerna announced that during the week of January 12, 2026 it will meet investors and ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/septerna-to-present-gpcr-pipeline-updates-at-jpm-conference?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/septerna-to-present-gpcr-pipeline-updates-at-jpm-conference?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BDCRKT87.USD","IE000M9KFDE8.USD","IE00BWXC8680.SGD","LU0345770993.USD","LU2462157665.USD","BK4599","IE00BJTD4V19.USD","LU0170899867.USD","LU2213496289.HKD","LU0208291251.USD","LU2357305700.SGD","SEPN","IE00BJTD4N35.SGD","LU1974910355.USD","LU1670627923.USD","IE00BYXW3230.USD","IE0034235188.USD","LU1032466523.USD","IE00B1BXHZ80.USD","LU2242649171.HKD","IE00B3S45H60.SGD","IE00B775SV38.USD","LU2381873111.SGD","LU0345769631.USD","IE00B1XK9C88.USD","LU0345770308.USD","LU1917777945.USD","SG9999002224.SGD","IE00BLSP4452.SGD","LU0006306889.USD","LU2417539215.USD","LU1261432733.SGD","LU0345769128.USD","LU1988902786.USD","LU2237443382.USD","LU0106831901.USD","LU1894683348.USD","SG9999002232.USD","LU0820561818.USD","LU2264538146.SGD","IE00BZ1G4Q59.USD","LU1162221912.USD","GPCR","LU0211328371.USD","LU2237443895.HKD","LU1244550221.USD","LU2756315318.SGD","LU2211815571.USD","LU0265550359.USD","LU0964807845.USD"],"gpt_icon":0},{"id":"2602492315","title":"Septerna Appoints Mark Wilson as Chief Legal Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2602492315","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602492315?lang=en_us&edition=fundamental","pubTime":"2026-01-09 06:04","pubTimestamp":1767909840,"startTime":"0","endTime":"0","summary":"Septerna, Inc. ( ($SEPN) ) has provided an announcement. On January 8, 2026, Septerna, Inc. announced it had appointed pharmaceutical and biotech v...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/septerna-appoints-mark-wilson-as-chief-legal-officer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/septerna-appoints-mark-wilson-as-chief-legal-officer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SEPN","BK4007"],"gpt_icon":0},{"id":"2602318239","title":"Septerna appoints Mark Wilson as chief legal officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2602318239","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602318239?lang=en_us&edition=fundamental","pubTime":"2026-01-09 05:16","pubTimestamp":1767906989,"startTime":"0","endTime":"0","summary":"Septerna (SEPN) announced the appointment of Mark Wilson as chief legal officer. Wilson joins Septerna from Nektar Therapeutics (NKTR), where he mo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/septerna-appoints-mark-wilson-as-chief-legal-officer-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/septerna-appoints-mark-wilson-as-chief-legal-officer-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","NKTR","SEPN"],"gpt_icon":0},{"id":"2602318590","title":"Press Release: Septerna Expands Leadership with Appointment of Industry Veteran Mark A. Wilson as Chief Legal Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2602318590","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602318590?lang=en_us&edition=fundamental","pubTime":"2026-01-09 05:05","pubTimestamp":1767906300,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., Jan. 08, 2026  -- Septerna, Inc. , a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor  drug discovery, today announced the appointment of Mark A. Wilson as Chief Legal Officer. Mr. Wilson is an accomplished pharmaceutical and biotech executive with more than 25 years of experience across intellectual property, corporate legal, strategic collaborations and corporate governance matters.\"We are thrilled to welcome Mark to the team,\" said Jeffrey Finer, M.D., Ph.D., Chief Executive Officer and Co-founder of Septerna. \"His deep expertise across intellectual property strategy and corporate legal matters will be instrumental as we continue to strengthen our governance framework and maximize the value of our portfolio and proprietary Native Complex Platform. Mark's leadership will be vital as we scale the capabilities needed to execute on our long-term strategy and deliver new medicines for patients.\". \"Septerna represents an ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SEPN","TM","BK4585","BK4588","BK4604","BK4099","GPCR","03160","BK4555","BK4599","BK4007"],"gpt_icon":0},{"id":"2593415568","title":"Septerna Initiated at Buy by Jones Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2593415568","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593415568?lang=en_us&edition=fundamental","pubTime":"2025-12-23 22:19","pubTimestamp":1766499540,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SEPN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 23, 2025 09:19 ET (14:19 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SEPN"],"gpt_icon":0},{"id":"2593049729","title":"Septerna Inc : Jonestrading Initiates Coverage With Buy Rating; Target Price $43","url":"https://stock-news.laohu8.com/highlight/detail?id=2593049729","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593049729?lang=en_us&edition=fundamental","pubTime":"2025-12-23 20:35","pubTimestamp":1766493343,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nFWN3XT0D5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SEPN"],"gpt_icon":0},{"id":"2592516192","title":"Raymond James Initiates Coverage on Septerna With Strong Buy Rating, $38 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2592516192","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592516192?lang=en_us&edition=fundamental","pubTime":"2025-12-19 20:19","pubTimestamp":1766146798,"startTime":"0","endTime":"0","summary":"Septerna, Inc. (SEPN) has an average rating of Buy and mean price target of $31.50, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major bank","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RJF","SEPN"],"gpt_icon":0},{"id":"2592642918","title":"Septerna to Present at 44th Annual J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2592642918","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592642918?lang=en_us&edition=fundamental","pubTime":"2025-12-17 21:00","pubTimestamp":1765976400,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., Dec.  17, 2025   -- Septerna, Inc. , a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor  drug discovery, today announced that Jeffrey Finer, M.D., Ph.D., chief executive officer and co-founder of Septerna, will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 3:45 p.m. PT in San Francisco. A live webcast of the presentation will be available in the investors section of the company’s website at www.septerna.com. The webcast will be archived for at least 30 days following the presentation. About SepternaSepterna, Inc. is a clinical-stage biotechnology company with a world-class team of GPCR experts and drug developers advancing cutting-edge science to unlock the full potential of GPCR therapies for patients with significant unmet needs. The company’s proprietary Native Complex Platform is designed to enable new approaches to GPCR drug discovery and has led to the development o","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/17/3206946/0/en/Septerna-to-Present-at-44th-Annual-J-P-Morgan-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234570918.USD","LU1244550221.USD","LU2023251221.USD","LU0225283273.USD","BK4585","LU0314104364.USD","LU2347655156.SGD","LU0528227936.USD","GPCR","LU0267386448.USD","LU1162221912.USD","LU2357305700.SGD","BK4581","LU1720051017.SGD","BK4127","LU0106261372.USD","LU2089284900.SGD","XLV","LU0912757837.SGD","XBI","SEPN","LU0320765646.SGD","LU0158827948.USD","LU1720051108.HKD","LU1668664300.SGD","LU2089283258.USD","LABU","LU0882574139.USD","LU1791710400.SGD","LU0029874061.USD","LU0106831901.USD","BK4599","LU2133065610.SGD","LU0971096721.USD","LU1244550494.USD","LU1244550577.SGD","BK4504","LU0795875086.SGD","LU2271345857.HKD","LU1791710582.SGD","BK4534","LU1074936037.SGD","HCSG","LU0158827781.USD","LU2111349929.HKD","BK4588","LU1548497426.USD","LU0128526141.USD","LU2028103732.USD","BK4516"],"gpt_icon":0},{"id":"2591644155","title":"Septerna Initiated at Buy by Truist Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2591644155","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591644155?lang=en_us&edition=fundamental","pubTime":"2025-12-15 22:03","pubTimestamp":1765807380,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SEPN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 15, 2025 09:03 ET (14:03 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SEPN","BK4007"],"gpt_icon":0},{"id":"2591461886","title":"Septerna Inc : Truist Securities Initiates Coverage With Buy Rating; Price Target $34","url":"https://stock-news.laohu8.com/highlight/detail?id=2591461886","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591461886?lang=en_us&edition=fundamental","pubTime":"2025-12-15 20:36","pubTimestamp":1765802164,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nFWN3XL0IK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SEPN","BK4007"],"gpt_icon":0},{"id":"2591643784","title":"Truist Initiates Septerna at Buy With $34 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2591643784","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591643784?lang=en_us&edition=fundamental","pubTime":"2025-12-15 19:49","pubTimestamp":1765799341,"startTime":"0","endTime":"0","summary":"Septerna (SEPN) has an average rating of buy and mean price target of $29.25, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SEPN"],"gpt_icon":0},{"id":"2585148590","title":"Septerna (SEPN) Is Up 9.9% After Swinging to Q3 Profit and Revenue Surge – Has the Bull Case Changed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2585148590","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585148590?lang=en_us&edition=fundamental","pubTime":"2025-11-23 15:21","pubTimestamp":1763882495,"startTime":"0","endTime":"0","summary":"Septerna, Inc. recently reported third quarter 2025 earnings, showing sales of US$21.5 million and net income of US$8.17 million, a turnaround from both low sales and a net loss in the same period last year.\nThis shift to profitability in a single quarter reflects a very large year-over-year improvement and suggests accelerated business momentum compared to recent performance.\nWe’ll explore how Septerna’s return to profitability and revenue growth informs its investment narrative after a...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-sepn/septerna/news/septerna-sepn-is-up-99-after-swinging-to-q3-profit-and-reven","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-sepn/septerna/news/septerna-sepn-is-up-99-after-swinging-to-q3-profit-and-reven","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SEPN"],"gpt_icon":0},{"id":"2585914546","title":"Cantor Fitzgerald Sticks to Their Buy Rating for Septerna, Inc. (SEPN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2585914546","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585914546?lang=en_us&edition=fundamental","pubTime":"2025-11-21 21:36","pubTimestamp":1763732184,"startTime":"0","endTime":"0","summary":"Cantor Fitzgerald analyst Joshua Schimmer maintained a Buy rating on Septerna, Inc. yesterday and set a price target of $25.00. The company’s share...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cantor-fitzgerald-sticks-to-their-buy-rating-for-septerna-inc-sepn-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cantor-fitzgerald-sticks-to-their-buy-rating-for-septerna-inc-sepn-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SEPN"],"gpt_icon":0},{"id":"2584443932","title":"Septerna price target raised to $34 from $28 at JPMorgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2584443932","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584443932?lang=en_us&edition=fundamental","pubTime":"2025-11-18 20:35","pubTimestamp":1763469310,"startTime":"0","endTime":"0","summary":"JPMorgan raised the firm’s price target on Septerna (SEPN) to $34 from $28 and keeps an Overweight rating on the shares following a transfer of cov...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/septerna-price-target-raised-to-34-from-28-at-jpmorgan-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/septerna-price-target-raised-to-34-from-28-at-jpmorgan-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SEPN"],"gpt_icon":0},{"id":"2584693562","title":"Septerna Inc : JP Morgan Raises Target Price to $34 From $28","url":"https://stock-news.laohu8.com/highlight/detail?id=2584693562","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584693562?lang=en_us&edition=fundamental","pubTime":"2025-11-18 18:19","pubTimestamp":1763461199,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nFWN3WU0FX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SEPN"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":55,"code":"91000000","status":"200"}]}}